Advances in stem cell biology and immune cell engineering bring diabetes cell therapies closer to reality. I n 2024, a woman ...
GlobalData on MSN10h
FDA removes hold on vTv’s cadisegliatin clinical programme for diabetesLast July, the agency placed a hold on the trial due to a chromatographic signal detected in a human ADME study of the ...
Automated insulin reduces hypoglycaemia in elderly, enabling safer diabetes management for seniors- read to learn more.
CleanPlates on MSN3h
Peptide Therapy Is Big Business. But Can You Get Peptides From Foods?Depending on your source of health news or the slant of your social media feed, you might be getting inundated these days with info about peptide therapy. This medical treatment involves using ...
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetesCATT1 Phase 3 trial expected to resume following ...
The review also found that some people managed to reverse their need for insulin therapy during intermittent fasting while under the supervision of a healthcare professional. In addition to ...
Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...
GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8539 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback